Axa S.A. Liva Nova PLC Transaction History

Axa S.A.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$50.12 - $58.87 $3.82 Million - $4.49 Million	-76,300 Reduced 95.02%	4,000 $211,000
Q2 2023 Aug 14, 2023	BUY	$42.28 - $51.43 $25,368 - $30,858	600 Added 0.75%	80,300 $4.13 Million
Q1 2023 May 15, 2023	BUY	$40.84 - $58.14 $2.81 Million - $4.01 Million	68,900 Added 637.96%	79,700 $3.47 Million
Q4 2022 Feb 14, 2023	BUY	$43.88 - $56.16 $96,536 - $123,551	2,200 Added 25.58%	10,800 $599,000
Q3 2022 Nov 14, 2022	BUY	$48.37 - $66.5 $415,982 - $571,900	8,600 New	8,600 $437,000
Q3 2020 Nov 13, 2020	SELL	$41.91 - $57.81 $322,707 - $445,137	-7,700 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$39.87 - $56.9 $306,999 - $438,130	7,700 New	7,700 $371,000
Q4 2018 Feb 13, 2019	SELL	$84.14 - $125.42 $370,216 - $551,848	-4,400 Closed	0 $0
Q3 2018 Nov 08, 2018	SELL	$101.02 - $130.95 $1.43 Million - $1.86 Million	-14,200 Reduced 76.34%	4,400 $545,000
Q2 2018 Aug 13, 2018	BUY	$81.75 - $105.37 $147,150 - $189,666	1,800 Added 10.71%	18,600 $1.86 Million
Q1 2018 May 14, 2018	BUY	$79.95 - $89.74 $1.34 Million - $1.51 Million	16,800 New	16,800 $1.49 Million

261

52.9M

316K

127K

Ticker LIVN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 53,545,700
Market Cap $2.52B
Description
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

Stay updated on Axa S.A. with notifications on news.